New combo aims to keep multiple myeloma in check
NCT ID NCT03173092
First seen Mar 28, 2026 · Last updated May 17, 2026 · Updated 9 times
Summary
This study looked at whether adding ixazomib to lenalidomide and dexamethasone can help control multiple myeloma in people who already received three cycles of bortezomib-based therapy. About 141 adults took part. The goal was to see how long the disease stayed under control. The study was stopped early, but results may still offer insights for managing this blood cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
American Oncology Partners of Maryland P.A
Bethesda, Maryland, 20817, United States
-
Arizona Oncology Associates
Tucson, Arizona, 85704, United States
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Central Care Cancer Center
Bolivar, Missouri, 65613, United States
-
Compassionate Care Research Group, Inc.
Fountain Valley, California, 92708, United States
-
Comprehensive Cancer Center of Nevada
Henderson, Nevada, 89074, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Innovative Clinical Research
Santa Ana, California, 92705, United States
-
Investigator Clinical Research - Indiana
Indianapolis, Indiana, 46260-2082, United States
-
Kansas City Veterans Affairs Medical Center
Kansas City, Missouri, 64128, United States
-
Los Angeles Cancer Network/(Formerly -Pacific Cancer Medical Center)
Anaheim, California, 92801-1824, United States
-
Millennium Physicians Association
Shenandoah, Texas, 77380-3256, United States
-
Saint Agnes Hospital
Baltimore, Maryland, 21229, United States
-
Texas Oncology -Tyler
Tyler, Texas, 75702, United States
-
Texas Oncology- Presbyterian Cancer Center Dallas
Dallas, Texas, 75231, United States
-
Texas Oncology-San Antonio Northwest
San Antonio, Texas, 78240, United States
-
Tri-Health Cancer Institute-Medical Oncology and Hematology Westside
Cincinnati, Ohio, 45247, United States
-
US Oncology Research
Colorado Springs, Colorado, 80907, United States
-
Willamette Valley Cancer Institute and Research Center - Springfield
Springfield, Oregon, 97477, United States
-
Winship Cancer Institute of Emory University
Atlanta, Georgia, 30303-001, United States
-
Woodlands Medical Specialists- Pensacola
Pensacola, Florida, 32503, United States
Conditions
Explore the condition pages connected to this study.